[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
doi: 10.3322/caac.v71.3
URL
|
[2] |
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1):19-28.
|
|
ZHENG R S, SUN K X, ZHANG S W, et al. Report of cancer epidemiology in China, 2015[J]. Chin J Oncol, 2019, 41(1):19-28.
|
[3] |
National Lung Screening Trial Research Team; ABERLE DR, ADAMS AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening[J]. N Engl J Med, 2011, 365(5):395-409.
doi: 10.1056/NEJMoa1102873
URL
|
[4] |
LABAKI W W, XIA M, MURRAY S, et al. Quantitative emphysema on low-dose ct imaging of the chest and risk of lung cancer and airflow obstruction: an analysis of the national lung screening trial[J]. Chest, 2021, 159(5):1812-1820.
doi: 10.1016/j.chest.2020.12.004
URL
|
[5] |
YONG P C, SIGEL K, DE-TORRES J P, et al. The effect of radiographic emphysema in assessing lung cancer risk[J]. Thorax, 2019, 74(9):858-864.
doi: 10.1136/thoraxjnl-2018-212457
pmid: 30723183
|
[6] |
ALBERG A J, BROCK MV, FORD J G, et al. Epidemio-logy of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest, 2013, 143(5 Suppl):e1S-e29S.
doi: 10.1378/chest.12-2345
URL
|
[7] |
YOULDEN D R, CRAMB S M, BAADE P D. The international epidemiology of lung cancer: geographical distribution and secular trends[J]. J Thorac Oncol, 2008, 3(8):819-831.
doi: 10.1097/JTO.0b013e31818020eb
pmid: 18670299
|
[8] |
DARBY S, HILL D, AUVINEN A, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies[J]. BMJ, 2005, 330(7485):223.
doi: 10.1136/bmj.38308.477650.63
URL
|
[9] |
TRAVIS L B, GOSPODAROWICZ M, CURTIS R E, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease[J]. J Natl Cancer Inst, 2002, 94(3):182-192.
pmid: 11830608
|
[10] |
MATAKIDOU A, EISEN T, HOULSTON R S. Systematic review of the relationship between family history and lung cancer risk[J]. Br J Cancer, 2005, 93(7):825-833.
doi: 10.1038/sj.bjc.6602769
|
[11] |
KOSHIOL J, ROTUNNO M, CONSONNI D, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study[J]. PLoS One, 2009, 4(10):e7380.
doi: 10.1371/journal.pone.0007380
URL
|
[12] |
DRISCOLL T, NELSON D I, STEENLAND K, et al. The global burden of disease due to occupational carcinogens[J]. Am J Ind Med, 2005, 48(6):419-431.
doi: 10.1002/ajim.20209
pmid: 16299703
|
[13] |
MCKEE B J, HASHIM J A, FRENCH R J, et al. Expe-rience With a CT Screening Program for Individuals at High Risk for Developing Lung Cancer[J]. J Am Coll Radiol, 2016, 13(2 Suppl):R8-R13.
doi: 10.1016/j.jacr.2015.12.006
URL
|
[14] |
中华医学会放射学分会心胸学组. 低剂量螺旋CT肺癌筛查专家共识[J]. 中华放射学杂志, 2015(5):328-335.
|
|
Cardiothoracic Group, Radiology Branch, Chinese Medical Association. Expert consensus on low-dose spiral CT lung cancer screening[J]. Chin J Radiol, 2015(5):328-335.
|
[15] |
BANKIER A A, MACMAHON H, GOO J M, et al. Reco-mmendations for Measuring Pulmonary Nodules at CT: a Statement from the Fleischner Society[J]. Radiology, 2017, 285(2):584-600.
doi: 10.1148/radiol.2017162894
URL
|
[16] |
BANKIER AA, MACMAHON H, GOO JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the fleischner society 2017[J]. Radiology, 2017, 284(1):228-243.
doi: 10.1148/radiol.2017161659
pmid: 28240562
|
[17] |
HAMMER M M, ECKEL A L, PALAZZO L L, et al. Cost-effectiveness of treatment thresholds for subsolid pulmonary nodules in CT lung cancer screening[J]. Radiology, 2021, 300(3):586-593.
doi: 10.1148/radiol.2021204418
URL
|
[18] |
YIP R, YANKELEVITZ D F, HU M, et al. Lung cancer deaths in the national lung screening trial attributed to nonsolid nodules[J]. Radiology, 2016, 281(2):589-596.
pmid: 27378239
|
[19] |
FUKUI M, SUZUKI K, MATSUNAGA T, et al. Surgical intervention for ground glass dominant lesions: observation or outright resection?[J]. Jpn J Clin Oncol, 2017, 47(8):749-754.
doi: 10.1093/jjco/hyx053
pmid: 28431123
|
[20] |
YI C A, LEE K S, KIM B T, et al. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT[J]. J Nucl Med, 2006, 47(3):443-450.
pmid: 16513614
|
[21] |
SCHILLACI O, TRAVASCIO L, BOLACCHI F, et al. Accuracy of early and delayed FDG PET-CT and of contras-tenhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients[J]. Radiol Med, 2009, 114(6):890-906.
doi: 10.1007/s11547-009-0400-z
URL
|
[22] |
ABERLE D R, ABTIN F, BROWN K. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial[J]. J Clin Oncol, 2013, 31(8):1002-1008.
doi: 10.1200/JCO.2012.43.3110
pmid: 23401434
|
[23] |
DE KONING H J, MEZA R, PLEVRITIS S K, et al. Bene-fits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force[J]. Ann Intern Med, 2014, 160(5):311-320.
doi: 10.7326/M13-2316
URL
|
[24] |
YOSHIZAWA A, MOTOI N, RIELY G J, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases[J]. Mod Pathol, 2011, 24(5):653-664.
|
[25] |
RUSSELL P A, WAINER Z, WRIGHT G M, et al. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification[J]. J Thorac Oncol, 2011, 6(9):1496-1504.
doi: 10.1097/JTO.0b013e318221f701
pmid: 21642859
|
[26] |
JETT J R, MIDTHUN D E. Commentary: CT screening for lung cancer--caveat emptor[J]. Oncologist, 2008, 13(4):439-444.
doi: 10.1634/theoncologist.2008-0027
pmid: 18448559
|
[27] |
National Lung Screening Trial Research Team; ABERLE D R, ADAMS A M, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening[J]. N Engl J Med, 2011, 365(5):395-409.
doi: 10.1056/NEJMoa1102873
URL
|
[28] |
PATZ EF J R, PINSKY P, GATSONIS C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer[J]. JAMA Intern Med, 2014, 174(2):269-274.
doi: 10.1001/jamainternmed.2013.12738
pmid: 24322569
|